Dr. Reddy's Laboratories Limited
₹1,226.7
INR-18.30(-1.47%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹104189.74 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹102817.04 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
18.76
Forward P/E
Price to Earnings ratio based on forecasted earnings
3.64
PEG Ratio
Price/Earnings to Growth ratio
3.64
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.61
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
60.40%
Operating Margin
Operating income as a percentage of revenue
23.39%
Return on Equity
Net income as a percentage of shareholders' equity
20.59%
Revenue (TTM)
Total revenue over trailing 12 months
₹28850.70 Cr+13.900000000000002%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹8270.50 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹66.62-0.7000000000000001%
Balance Sheet
Total Cash
Total cash and short-term investments
₹9462.60 Cr
Total Debt
Total short-term and long-term debt
₹3067.50 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
10.41%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1049.42 - ₹1421.49
Beta
Measure of stock's volatility compared to the market
0.31
Shares Outstanding
Total number of shares issued by the company
₹83.30 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
12.54%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.63%
Payout Ratio
Percentage of earnings paid as dividends
12.00%